ABIOMED INC (ABMD)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
1
Reporting holders
$381
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | $381 | 1 | 0.00% | 19q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $381 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $381 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $381 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $381 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 1 | $381 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2025 | 1 | $381 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 1 | $381 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 1 | $381 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 1 | $381 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2024 | 1 | $381 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2023 | 1 | $381 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2023 | 1 | $381 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2023 | 1 | $381 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 2 | $1.9K | 3,940 | 0 | 0 | 0 | 0.0% |
| Q4 2022 | 8 | $45.7M | 10,981 | 1 | 1 | 4 | 100.0% |
| Q3 2022 | 513 | $10.7B | 43,276,031 | 50 | 170 | 167 | 0.6% |
| Q2 2022 | 495 | $10.7B | 42,814,284 | 61 | 179 | 148 | 0.9% |
| Q1 2022 | 500 | $14.2B | 42,536,120 | 54 | 159 | 172 | 0.6% |
| Q4 2021 | 494 | $15.4B | 42,073,614 | 42 | 151 | 172 | 1.7% |
| Q3 2021 | 498 | $13.6B | 41,253,953 | 51 | 160 | 170 | 1.6% |
| Q2 2021 | 477 | $13.2B | 41,797,377 | 34 | 153 | 174 | 1.3% |
| Q1 2021 | 486 | $13.3B | 41,264,718 | 44 | 149 | 183 | 1.3% |
| Q4 2020 | 503 | $14.9B | 44,328,463 | 50 | 157 | 172 | 3.7% |
| Q3 2020 | 503 | $12.3B | 42,821,630 | 80 | 156 | 165 | 3.3% |
| Q2 2020 | 462 | $10.9B | 43,605,560 | 94 | 128 | 163 | 3.1% |
| Q1 2020 | 409 | $6.6B | 43,888,054 | 38 | 145 | 149 | 3.6% |
| Q4 2019 | 467 | $8.1B | 45,155,101 | 63 | 141 | 154 | 4.9% |
| Q3 2019 | 443 | $7.7B | 41,701,195 | 49 | 167 | 145 | 3.8% |
| Q2 2019 | 487 | $11.6B | 42,367,005 | 46 | 181 | 179 | 4.8% |
| Q1 2019 | 563 | $11.9B | 40,128,039 | 78 | 201 | 181 | 3.8% |
| Q4 2018 | 533 | $13.5B | 40,361,989 | 7 | 13 | 10 | 2.7% |